mhurhangee/ep-ind-claims huggingface dataset:
A computer-implemented method for controlling a local utility, comprising: at a client computer having a processor and memory storing instructions for execution by the processor: at a local utility: receiving a first request originating from a web browser executed by the client computer, the first request including a first token, wherein the first request and the first token are received by the local utility via a local web server of the local utility, wherein the local web server is executed by the client computer; authenticating the first token, including sending the first token to an authentication server remote from the client computer; in response to authenticating the first token, generating a second token at the local utility; sending the second token to the web browser for inclusion in subsequent requests from the web browser to the local utility; receiving a second request from the web browser, wherein the second request includes a third token and one or both of a local utility control command and a local utility status request; determining whether the third token matches the second token; in accordance with a determination that the second and third tokens match, taking one or more actions based on the content of the second request; and in accordance with a determination the second and third tokens do not match, taking no action based on the content of the second request. receiving a first request originating from a web browser executed by the client computer, the first request including a first token, wherein the first request and the first token are received by the local utility via a local web server of the local utility, wherein the local web server is executed by the client computer; authenticating the first token, including sending the first token to an authentication server remote from the client computer; in response to authenticating the first token, generating a second token at the local utility; sending the second token to the web browser for inclusion in subsequent requests from the web browser to the local utility; receiving a second request from the web browser, wherein the second request includes a third token and one or both of a local utility control command and a local utility status request; determining whether the third token matches the second token; in accordance with a determination that the second and third tokens match, taking one or more actions based on the content of the second request; and in accordance with a determination the second and third tokens do not match, taking no action based on the content of the second request.
A method for manufacturing a powder based article comprising one portion of a first material and at least one portion of a second material, said method comprising the steps of: - arranging at least a first body comprising a powder of the second material and a gasifiable material in a selected portion or selected portions in a capsule defining the shape of the article, wherein the powder of the second material is held by the gasifiable material; - filling the capsule with a powder of the first material; - removing the gasifiable material; - sealing the capsule; - heating the capsule under increased pressure to a temperature at which the powders of the first and second materials densifies to a compact article, and characterized in that the body comprises one or more shells of gasifiable polymer material and a powder of at least the first material or at least the second material, wherein the shell or shells are filled or prefilled with at least a powder of the second material. - arranging at least a first body comprising a powder of the second material and a gasifiable material in a selected portion or selected portions in a capsule defining the shape of the article, wherein the powder of the second material is held by the gasifiable material; - filling the capsule with a powder of the first material; - removing the gasifiable material; - sealing the capsule; - heating the capsule under increased pressure to a temperature at which the powders of the first and second materials densifies to a compact article, and characterized in that the body comprises one or more shells of gasifiable polymer material and a powder of at least the first material or at least the second material, wherein the shell or shells are filled or prefilled with at least a powder of the second material.
A method for building a representation of behavior of a container, the method comprising: Injecting a probe in an operating system associated with the container to monitor system calls to the operating system coming from the container, producing records for respective system calls, each record containing an identifier of a system call and a stack size used by the container for the system call, the records being put in an ordered queue, processing the records in the ordered queue into a graph comprising nodes respectively associated with used stack sizes and edges respectively associated with identifiers of system call between nodes, wherein an edge from one record is associated with the identifier of the system call of the one record and links a node associated with a previous record to the node associated with the one record. Injecting a probe in an operating system associated with the container to monitor system calls to the operating system coming from the container, producing records for respective system calls, each record containing an identifier of a system call and a stack size used by the container for the system call, the records being put in an ordered queue, processing the records in the ordered queue into a graph comprising nodes respectively associated with used stack sizes and edges respectively associated with identifiers of system call between nodes, wherein an edge from one record is associated with the identifier of the system call of the one record and links a node associated with a previous record to the node associated with the one record.
A pharmaceutical composition which comprises a compound of formula I where R 1 and R 2 are hydrogen; X signifies a methylene group; Y represents an atom of oxygen or sulphur; n represents the number 0, 1, 2 or 3 and m represents the number 0 or 1; R 3 signifies a pyridine N-oxide group according to the formula A, B, or C, which is connected as indicated by the unmarked bond: where R 4, R 5, R 6 and R 7 are the same or different, and signify hydrogen, C 1 -C 6 alkyl, C 1 -C 6 thioalkyl, C 1 -C 6 alkoxy, aryloxy or thioaryl group, C 1 -C 6 alkanoyl or aroyl group, optionally substituted aryl group, amino, C 1 -C 6 alkylamino, C 1 -C 6 dialkylamino cycloalkylamino or heterocycloalkylamino group, C 1 -C 6 alkylsulphonyl or arylsulphonyl group, halogen, haloalkyl, trifluoromethyl, cyano, nitro or heteroaryl group, or taken together signify aliphatic or heteroaliphatic rings or aromatic or heteroaromatic rings; the term alkyl means carbon chains, straight or branched, containing from one b six carbon atoms; the term aryl means a phenyl or naphthyl group, optionally substituted by alkoxy or halogen groups; the term heterocycloalkyl represents a four to eight-membered cyclic ring optionally incorporating other atoms of oxygen, sulphur or nitrogen; the term heteroaryl represents a five or six-membered ring incorporating an atom of sulphur, oxygen or nitrogen; the term halogen represents fluorine, chlorine bromine or iodine; or a pharmaceutically acceptable salt thereof, which pharmaceutical composition is an individual dosage unit comprising 1 to 500 mg of said compound or salt.
A filter apparatus comprising at least one filter (116; 116A; 116D; 216; 316), each filter being tunable and comprising at least one capacitor arrangement (128a; 128b), and the capacitor arrangement comprises a plurality of first capacitors (506; 614), a plurality of second capacitors (510; 618), and a plurality of switches (512; 620), each switch being switchable between a non-conducting mode and a conducting mode, characterized in that the capacitor arrangement (128a; 128b) comprises a series connection (530; 630) of the plurality of first capacitors (506; 614) and in that the plurality of second capacitors and the plurality of switches are arranged such that different ones of the second capacitors are connectable, by means of the plurality of switches, to different potentials of the series connection of the plurality of first capacitors in order to tune the filter by adjusting the capacitance of the filter.
Testosterone or a pharmaceutically acceptable ester or salt thereof for use in a method of treating hypogonadism, reduced fertility, lack of libido or erectile dysfunction, osteoporosis or anemia in a subject, wherein the subject is susceptible to a change in his or her hematocrit blood levels in response to a change in testosterone blood levels and the method involves modulating or controlling the level of hematocrit in the subject, wherein the method comprises subcutaneously administering to the subject testosterone or a pharmaceutically acceptable ester or salt thereof, such that the maximum concentration of the testosterone or the pharmaceutically acceptable ester or salt thereof in the blood (serum or plasma) of the subject, following administration of a dose of the testosterone or of the pharmaceutically acceptable ester or salt thereof to the subject ("C max "), is maintained at a value from about 300 ng/dl to about 1800 ng/dl, and wherein the level of hematocrit produced in the subject following the subcutaneous administration of the dose of the testosterone or the pharmaceutically acceptable ester or salt thereof does not exceed 70%.
A wear resistant seal system, adapted for resisting wear of a rotating part in a gas turbine engine as it rotates against a stationary part in the engine, the system comprising: an axially rotatable member including an abrasive tip having a first tensile strength; and a stationary structure radially exterior and adjacent to the rotatable member, the stationary structure including an abradable material, and characterised by the stationary structure including: a matrix material having a second tensile strength that, at least in a first temperature range, is lower than the first tensile strength; and a filler material interspersed with the matrix material, wherein the matrix material includes at least one of Cu 5 Al, Cu 8 Al 1 Fe or Cu 38 Ni. an axially rotatable member including an abrasive tip having a first tensile strength; and a stationary structure radially exterior and adjacent to the rotatable member, the stationary structure including an abradable material, and characterised by the stationary structure including: a matrix material having a second tensile strength that, at least in a first temperature range, is lower than the first tensile strength; and a filler material interspersed with the matrix material, wherein the matrix material includes at least one of Cu 5 Al, Cu 8 Al 1 Fe or Cu 38 Ni. a matrix material having a second tensile strength that, at least in a first temperature range, is lower than the first tensile strength; and a filler material interspersed with the matrix material, wherein the matrix material includes at least one of Cu 5 Al, Cu 8 Al 1 Fe or Cu 38 Ni.
An electronic communication gateway intended to be placed on board an aircraft and configured to communicate with an external electronic system, positioned outside the aircraft, said information being exchanged in the form of radio waves between the external system and the aircraft, the electronic communication gateway comprising: - an acquisition module configured to acquire information from the external system, and - a transmission module configured to transmit the acquired information to an avionics system (20, 22) on board the aircraft, characterized in that the acquisition module is configured to acquire, from the external system, a current date upon powering on the gateway, and the transmission module is configured to send the acquired current date to the avionics system (20, 22), for the initialization of said avionics system (20, 22). - an acquisition module configured to acquire information from the external system, and - a transmission module configured to transmit the acquired information to an avionics system (20, 22) on board the aircraft,
A method for producing low-salt cheese comprising the following steps: a) providing a milk substrate; b) inoculating the milk substrate with a lactic acid bacteria starter culture which is Glu decarboxylation (glutamate decarboxylation - GAD) negative; c) adding a coagulant to the milk substrate; d) allowing the resulting product from steps b) and c) to coagulate; e) using the coagulum from step d) to produce cheese; f) optionally storing the cheese; wherein the total GAD activity results in that below 0.05 mM γ-amino butyric acid (GABA) is produced following incubation in a glutamate containing milk medium at 35°C for 24 hours; and wherein the low-salt cheese is selected from the group consisting of Cheddar containing an amount of salt in the range 0.1 up to 1.5% - excluding 1.5%; Parmesan containing an amount of salt in the range 0.1 up to 2.5% - excluding 2.5%; Mozzarella containing an amount of salt in the range 0.1 up to 0.7% - excluding 0.7%; Emmental containing an amount of salt in the range 0.1 up to 0.7% - excluding 0.7%; Danbo containing an amount of salt in the range 0.1 up to 1.4% - excluding 1.4%; Gouda containing an amount of salt in the range 0.1 up to 1.5% - excluding 1.5%; Edam containing an amount of salt in the range 0.1 up to 1.5% - excluding 1.5%; Feta-type containing an amount of salt in the range 0.1 up to 3.0% - excluding 3.0%; Blue cheese containing an amount of salt in the range 0.1 up to 3.5% - excluding 3.5%; and Camembert containing an amount of salt in the range 0.1 up to 2.5% - excluding 2.5%. and wherein the method comprises the further step of inoculating the milk substrate with Lactobacillus helveticus ( Lb. helveticus) strain, said strain is GAD-negative; and wherein a strain or LAB starter culture is considered to be GAD-negative if the strain or culture produces less than 0.05 mM GABA in milk, as determined according to the following assay: Reconstituted skim milk, at 9.5%, boiled, is inoculated with 10E8 cell forming units of the strain/culture per mL of milk and allowed to stand at 35°C for 24 hours - After the 24 hours the pH has dropped below 5.0, and the content of GABA is measured - If the concentration of GABA is lower than 0.05 mM, the strain/culture is considered to be glutamate decarboxylase negative. a) providing a milk substrate; b) inoculating the milk substrate with a lactic acid bacteria starter culture which is Glu decarboxylation (glutamate decarboxylation - GAD) negative; c) adding a coagulant to the milk substrate; d) allowing the resulting product from steps b) and c) to coagulate; e) using the coagulum from step d) to produce cheese; f) optionally storing the cheese;
A spinal implant (12; 112; 412) comprising: a body including a first vertebral engaging surface (18; 118; 418) and a second vertebral engaging surface (20; 120; 420), at least one of the surfaces (18, 20; 118, 120;418, 420) including a plurality of tissue penetrating members (22; 122; 460, 462), each of the plurality of tissue penetrating members (22; 122; 460, 462) including a cutting surface (40; 140; 466), characterized in that each of the plurality of tissue penetrating members (22; 122; 460, 462) comprises an undercut surface that defines a tunnel (44, 144, 470), and each of the plurality of tissue penetrating members (22; 122; 460, 462) comprises a guide surface (46, 48; 146; 472) to guide tissue cut by the cutting surface (40; 140; 466) into the tunnel (44, 144, 470), wherein the plurality of tissue penetrating members (22; 122; 460, 462) with the respective tunnels are disposed in a serial configuration to form linear rows extending along the entire extend of the at least one of the surfaces (18, 20; 118, 120; 418, 420). a body including a first vertebral engaging surface (18; 118; 418) and a second vertebral engaging surface (20; 120; 420), at least one of the surfaces (18, 20; 118, 120;418, 420) including a plurality of tissue penetrating members (22; 122; 460, 462), each of the plurality of tissue penetrating members (22; 122; 460, 462) including a cutting surface (40; 140; 466), characterized in that each of the plurality of tissue penetrating members (22; 122; 460, 462) comprises an undercut surface that defines a tunnel (44, 144, 470), and each of the plurality of tissue penetrating members (22; 122; 460, 462) comprises a guide surface (46, 48; 146; 472) to guide tissue cut by the cutting surface (40; 140; 466) into the tunnel (44, 144, 470), wherein the plurality of tissue penetrating members (22; 122; 460, 462) with the respective tunnels are disposed in a serial configuration to form linear rows extending along the entire extend of the at least one of the surfaces (18, 20; 118, 120; 418, 420).
A thermoset which can be obtained by a method in which in a first step a compound or a mixture of compounds having the general formula I is reacted with a compound of the general formula II R 2 -H II giving a mixture of compounds of the general formula III which in a second step is reacted in a radical polymerization operation to give a thermoset, wherein the designations are: R 1 hydrogen, a C 1 -C 6 alkyl, a C 6 -C 12 aryl or a C 6 -C 12 alkylaryl, R 2 R 3 wherein within a compound of formula III and within the sub-unit A' the residues R 3 can be the same or different and wherein the compound or the mixture of compounds of formula I is used in a ratio to the compound of formula II so that the ratio of in the mixture produced in the first step of compounds III is in the range of between 4:1 and 1:4, and wherein X wherein R 4 is hydrogen, CH 2 OH, OH, a C 1 -C 6 alkyl, a C 6 -C 12 aryl, a C 6 -C 12 alkylaryl or Z wherein R 5 is hydrogen, CH 2 OH, OH, a C 1 -C 6 alkyl, a C 6 -C 12 aryl, a C 6 -C 12 alkylaryl or and n in the compound according to formula I or the mixtures of compounds according to formulae I and III represents a mean chain length in the range of between 1 and 100. R 1 hydrogen, a C 1 -C 6 alkyl, a C 6 -C 12 aryl or a C 6 -C 12 alkylaryl, R 2 R 3
A solar cell comprising: a semiconductor substrate doped with p-type impurities; an emitter region which is positioned at the semiconductor substrate and forms a p-n junction along with the semiconductor substrate; a first electrode which is positioned on the semiconductor substrate and is connected to the emitter region; a second electrode which is positioned on the semiconductor substrate and is connected to the semiconductor substrate; and a second electrode current collector which is positioned on the semiconductor substrate and is connected to the second electrode, characterized in that the second electrode current collector includes a plurality of conductors spaced apart from each other in a first direction (y) parallel to an extension direction of a conductive line positioned on the second electrode current collector, at least one of the plurality of conductors overlap with the second electrode in the first direction (y) and in a second direction (x) crossing the first direction (y), and a first overlap distance (d21, d22) between the second electrode and the at least one of the plurality of conductors in the first direction (y) is less than a second overlap distance (d11, d12) between the second electrode and the at least one of the plurality of conductors in the second direction (x). a semiconductor substrate doped with p-type impurities; an emitter region which is positioned at the semiconductor substrate and forms a p-n junction along with the semiconductor substrate; a first electrode which is positioned on the semiconductor substrate and is connected to the emitter region; a second electrode which is positioned on the semiconductor substrate and is connected to the semiconductor substrate; and a second electrode current collector which is positioned on the semiconductor substrate and is connected to the second electrode, characterized in that the second electrode current collector includes a plurality of conductors spaced apart from each other in a first direction (y) parallel to an extension direction of a conductive line positioned on the second electrode current collector, at least one of the plurality of conductors overlap with the second electrode in the first direction (y) and in a second direction (x) crossing the first direction (y), and a first overlap distance (d21, d22) between the second electrode and the at least one of the plurality of conductors in the first direction (y) is less than a second overlap distance (d11, d12) between the second electrode and the at least one of the plurality of conductors in the second direction (x).
A compound represented by Formula I, or a pharmaceutical acceptable salt thereof, for use in preventing and/or treating diabetes or a metabolic-related condition or disorder, wherein the compound is for administration at a dose of 0.1 to 5 mg/kg per day, and Formula I is: wherein A is C 5 alkyl, C 6 alkyl, C 5 alkenyl, C 6 alkenyl, C -(CH 2) n -CH 3 or CH -(CH 2) n -CH 3 wherein n is 3 or 4; R 1 is H, F or OH; R 2 is C 5 alkyl, C 6 alkyl, C 5 alkenyl, C 6 alkenyl, C -(CH 2) n -CH 3 or CH -(CH 2) n -CH 3 wherein n is 3 or 4; R 3 is H, F, OH or CH 2 Ph; R 4 is H, F or OH; Q is 1) (CH 2) m C OH wherein m is 1 or 2, 2) CH(CH 3)C OH, 3) C(CH 3) 2 C OH, 4) CH -C OH, 5) CF 2 -C OH, or 6) C -C OH, characterised in that said diabetes or metabolic-related condition or disorder is selected from the group consisting of Type I diabetes, Type II diabetes, Type III diabetes (Alzheimer), maturity-onset diabetes of the young, latent autoimmune diabetes of adults (LADA), gestational diabetes, hyperglycemia, glucose intolerance, insulin resistance, hyperinsulinemia, hypercholesterolemia, hyperlipoproteinemia, hyperlipidemia, hypertriglyceridemia, dyslipidemia, diabetic neuropathy, diabetic retinopathy, atherosclerosis, sexual dysfunction, and metabolic syndrome. A is C 5 alkyl, C 6 alkyl, C 5 alkenyl, C 6 alkenyl, C -(CH 2) n -CH 3 or CH -(CH 2) n -CH 3 wherein n is 3 or 4; R 1 is H, F or OH; R 2 is C 5 alkyl, C 6 alkyl, C 5 alkenyl, C 6 alkenyl, C -(CH 2) n -CH 3 or CH -(CH 2) n -CH 3 wherein n is 3 or 4; R 3 is H, F, OH or CH 2 Ph; R 4 is H, F or OH; Q is 1) (CH 2) m C OH wherein m is 1 or 2, 2) CH(CH 3)C OH, 3) C(CH 3) 2 C OH, 4) CH -C OH, 5) CF 2 -C OH, or 6) C -C OH, 1) (CH 2) m C OH wherein m is 1 or 2, 2) CH(CH 3)C OH, 3) C(CH 3) 2 C OH, 4) CH -C OH, 5) CF 2 -C OH, or 6) C -C OH,
A method of heating a rotor of a vacuum pump, in particular of a turbomolecular pump, which has a rotor which is drivable by means of an electric motor and whose temperature is in the range of an environmental temperature during a first operating phase of the vacuum pump, wherein eddy currents are generated within the rotor during a second operating phase and effect a heating of the rotor to a desired temperature above the environmental temperature, characterized in that the eddy currents are generated by reducing the efficiency of the electric motor.
A patch case which holds a microneedle patch comprising a support film, the patch case being made of a thermoplastic polymer and the support film being heat-sealable to the thermoplastic polymer, wherein the microneedle patch is attached to the underside of the edge of the patch case by thermal fusion and wherein the break strength of the heat fusion portion is 0.01 to 20 N. wherein the microneedle patch is attached to the underside of the edge of the patch case by thermal fusion and wherein the break strength of the heat fusion portion is 0.01 to 20 N.